Carlisle Companies Incorporated (CSL)

Total asset turnover

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue US$ in thousands 4,586,900 5,449,400 4,810,300 3,969,900 4,484,600
Total assets US$ in thousands 6,620,000 7,222,000 7,246,800 5,866,400 5,496,000
Total asset turnover 0.69 0.75 0.66 0.68 0.82

December 31, 2023 calculation

Total asset turnover = Revenue ÷ Total assets
= $4,586,900K ÷ $6,620,000K
= 0.69

Carlisle Companies Inc.'s total asset turnover has fluctuated over the past five years. The ratio was highest in 2022 at 0.91, indicating that the company generated $0.91 in sales for each dollar invested in total assets. However, in 2021 and 2023, the total asset turnover decreased to 0.66 and 0.69, respectively, implying a decline in efficiency in utilizing its assets to generate sales.

The company's performance in 2020 was slightly better with a total asset turnover of 0.72, while in 2019 it was 0.88, showing a higher level of efficiency in asset utilization compared to the more recent years. Overall, the declining trend in total asset turnover suggests that Carlisle Companies Inc. may need to focus on improving its asset management to enhance operational efficiency and drive higher sales in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
Total asset turnover
Carlisle Companies Incorporated
CSL
0.69
West Pharmaceutical Services Inc
WST
0.76